Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.
Identifieur interne : 00B239 ( Ncbi/Checkpoint ); précédent : 00B238; suivant : 00B240Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.
Auteurs : B C Vrouenraets [Pays-Bas] ; J M Klaase ; B B Kroon ; B N Van Geel ; A M Eggermont ; H R FranklinSource :
- Archives of surgery (Chicago, Ill. : 1960) [ 0004-0010 ] ; 1995.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Amyotrophie (), Femelle, Humains, Hypersensibilité médicamenteuse, Lymphoedème (), Melphalan (effets indésirables), Melphalan (usage thérapeutique), Membres, Morbidité, Mâle, Mélanome (traitement médicamenteux), Perfusion régionale de chimiothérapie anticancéreuse, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs cutanées (traitement médicamenteux).
- MESH :
- effets indésirables : Melphalan.
- traitement médicamenteux : Mélanome, Tumeurs cutanées.
- usage thérapeutique : Melphalan.
- Adulte, Adulte d'âge moyen, Amyotrophie, Femelle, Humains, Hypersensibilité médicamenteuse, Lymphoedème, Membres, Morbidité, Mâle, Perfusion régionale de chimiothérapie anticancéreuse, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Chemotherapy, Cancer, Regional Perfusion, Drug Hypersensitivity, Extremities, Female, Humans, Lymphedema (chemically induced), Male, Melanoma (drug therapy), Melphalan (adverse effects), Melphalan (therapeutic use), Middle Aged, Morbidity, Muscular Atrophy (chemically induced), Skin Neoplasms (drug therapy).
- MESH :
- chemical , adverse effects : Melphalan.
- chemically induced : Lymphedema, Muscular Atrophy.
- drug therapy : Melanoma, Skin Neoplasms.
- chemical , therapeutic use : Melphalan.
- Adult, Aged, Aged, 80 and over, Chemotherapy, Cancer, Regional Perfusion, Drug Hypersensitivity, Extremities, Female, Humans, Male, Middle Aged, Morbidity.
Abstract
To determine the influence of acute regional toxic reactions on the incidence and characteristics of long-term morbidity after regional isolated perfusion with melphalan.
PubMed: 7802575
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 005445
- to stream PubMed, to step Curation: 005445
- to stream PubMed, to step Checkpoint: 005445
- to stream Ncbi, to step Merge: 00B239
- to stream Ncbi, to step Curation: 00B239
Links to Exploration step
pubmed:7802575Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.</title><author><name sortKey="Vrouenraets, B C" sort="Vrouenraets, B C" uniqKey="Vrouenraets B" first="B C" last="Vrouenraets">B C Vrouenraets</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam.</nlm:affiliation><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName><wicri:orgArea>Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis)</wicri:orgArea></affiliation></author><author><name sortKey="Klaase, J M" sort="Klaase, J M" uniqKey="Klaase J" first="J M" last="Klaase">J M Klaase</name></author><author><name sortKey="Kroon, B B" sort="Kroon, B B" uniqKey="Kroon B" first="B B" last="Kroon">B B Kroon</name></author><author><name sortKey="Van Geel, B N" sort="Van Geel, B N" uniqKey="Van Geel B" first="B N" last="Van Geel">B N Van Geel</name></author><author><name sortKey="Eggermont, A M" sort="Eggermont, A M" uniqKey="Eggermont A" first="A M" last="Eggermont">A M Eggermont</name></author><author><name sortKey="Franklin, H R" sort="Franklin, H R" uniqKey="Franklin H" first="H R" last="Franklin">H R Franklin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1995">1995</date><idno type="RBID">pubmed:7802575</idno><idno type="pmid">7802575</idno><idno type="wicri:Area/PubMed/Corpus">005445</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005445</idno><idno type="wicri:Area/PubMed/Curation">005445</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005445</idno><idno type="wicri:Area/PubMed/Checkpoint">005445</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005445</idno><idno type="wicri:Area/Ncbi/Merge">00B239</idno><idno type="wicri:Area/Ncbi/Curation">00B239</idno><idno type="wicri:Area/Ncbi/Checkpoint">00B239</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.</title><author><name sortKey="Vrouenraets, B C" sort="Vrouenraets, B C" uniqKey="Vrouenraets B" first="B C" last="Vrouenraets">B C Vrouenraets</name><affiliation wicri:level="3"><nlm:affiliation>Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam.</nlm:affiliation><country>Pays-Bas</country><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName><wicri:orgArea>Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis)</wicri:orgArea></affiliation></author><author><name sortKey="Klaase, J M" sort="Klaase, J M" uniqKey="Klaase J" first="J M" last="Klaase">J M Klaase</name></author><author><name sortKey="Kroon, B B" sort="Kroon, B B" uniqKey="Kroon B" first="B B" last="Kroon">B B Kroon</name></author><author><name sortKey="Van Geel, B N" sort="Van Geel, B N" uniqKey="Van Geel B" first="B N" last="Van Geel">B N Van Geel</name></author><author><name sortKey="Eggermont, A M" sort="Eggermont, A M" uniqKey="Eggermont A" first="A M" last="Eggermont">A M Eggermont</name></author><author><name sortKey="Franklin, H R" sort="Franklin, H R" uniqKey="Franklin H" first="H R" last="Franklin">H R Franklin</name></author></analytic><series><title level="j">Archives of surgery (Chicago, Ill. : 1960)</title><idno type="ISSN">0004-0010</idno><imprint><date when="1995" type="published">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Chemotherapy, Cancer, Regional Perfusion</term><term>Drug Hypersensitivity</term><term>Extremities</term><term>Female</term><term>Humans</term><term>Lymphedema (chemically induced)</term><term>Male</term><term>Melanoma (drug therapy)</term><term>Melphalan (adverse effects)</term><term>Melphalan (therapeutic use)</term><term>Middle Aged</term><term>Morbidity</term><term>Muscular Atrophy (chemically induced)</term><term>Skin Neoplasms (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Amyotrophie ()</term><term>Femelle</term><term>Humains</term><term>Hypersensibilité médicamenteuse</term><term>Lymphoedème ()</term><term>Melphalan (effets indésirables)</term><term>Melphalan (usage thérapeutique)</term><term>Membres</term><term>Morbidité</term><term>Mâle</term><term>Mélanome (traitement médicamenteux)</term><term>Perfusion régionale de chimiothérapie anticancéreuse</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs cutanées (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Melphalan</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term><term>Muscular Atrophy</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Melphalan</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Melphalan</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Melphalan</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Chemotherapy, Cancer, Regional Perfusion</term><term>Drug Hypersensitivity</term><term>Extremities</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Morbidity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Amyotrophie</term><term>Femelle</term><term>Humains</term><term>Hypersensibilité médicamenteuse</term><term>Lymphoedème</term><term>Membres</term><term>Morbidité</term><term>Mâle</term><term>Perfusion régionale de chimiothérapie anticancéreuse</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To determine the influence of acute regional toxic reactions on the incidence and characteristics of long-term morbidity after regional isolated perfusion with melphalan.</div></front></TEI><affiliations><list><country><li>Pays-Bas</li></country><region><li>Hollande-Septentrionale</li></region><settlement><li>Amsterdam</li></settlement></list><tree><noCountry><name sortKey="Eggermont, A M" sort="Eggermont, A M" uniqKey="Eggermont A" first="A M" last="Eggermont">A M Eggermont</name><name sortKey="Franklin, H R" sort="Franklin, H R" uniqKey="Franklin H" first="H R" last="Franklin">H R Franklin</name><name sortKey="Klaase, J M" sort="Klaase, J M" uniqKey="Klaase J" first="J M" last="Klaase">J M Klaase</name><name sortKey="Kroon, B B" sort="Kroon, B B" uniqKey="Kroon B" first="B B" last="Kroon">B B Kroon</name><name sortKey="Van Geel, B N" sort="Van Geel, B N" uniqKey="Van Geel B" first="B N" last="Van Geel">B N Van Geel</name></noCountry><country name="Pays-Bas"><region name="Hollande-Septentrionale"><name sortKey="Vrouenraets, B C" sort="Vrouenraets, B C" uniqKey="Vrouenraets B" first="B C" last="Vrouenraets">B C Vrouenraets</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B239 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 00B239 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:7802575
|texte= Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:7802575" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |